272 related articles for article (PubMed ID: 20708968)
1. Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design.
Buehler PW; D'Agnillo F; Schaer DJ
Trends Mol Med; 2010 Oct; 16(10):447-57. PubMed ID: 20708968
[TBL] [Abstract][Full Text] [Related]
2. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
3. Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems.
Buehler PW; Alayash AI
Transfusion; 2004 Oct; 44(10):1516-30. PubMed ID: 15383027
[TBL] [Abstract][Full Text] [Related]
4. Setbacks in blood substitutes research and development: a biochemical perspective.
Alayash AI
Clin Lab Med; 2010 Jun; 30(2):381-9. PubMed ID: 20513557
[TBL] [Abstract][Full Text] [Related]
5. Blood substitutes as pharmacotherapies in clinical practice.
Jahr JS; Walker V; Manoochehri K
Curr Opin Anaesthesiol; 2007 Aug; 20(4):325-30. PubMed ID: 17620840
[TBL] [Abstract][Full Text] [Related]
6. Potential uses of hemoglobin-based oxygen carriers in critical care medicine.
Creteur J; Vincent JL
Crit Care Clin; 2009 Apr; 25(2):311-24, Table of Contents. PubMed ID: 19341911
[TBL] [Abstract][Full Text] [Related]
7. Basic science offers a challenge for developing hemoglobin based oxygen carriers into therapeutic agents.
Bucci E
Artif Cells Blood Substit Immobil Biotechnol; 2011 Aug; 39(4):206-13. PubMed ID: 21692690
[TBL] [Abstract][Full Text] [Related]
8. Oxygen therapeutics--current concepts.
Hill SE
Can J Anaesth; 2001 Apr; 48(4 Suppl):S32-40. PubMed ID: 11336435
[TBL] [Abstract][Full Text] [Related]
9. The development of hemoglobin solutions as red cell substitutes.
Ogden JE; Parry ES
Int Anesthesiol Clin; 1995; 33(1):115-29. PubMed ID: 7635553
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery.
Cheng DC
Can J Anaesth; 2001 Apr; 48(4 Suppl):S41-8. PubMed ID: 11336436
[TBL] [Abstract][Full Text] [Related]
11. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
Alayash AI; D'Agnillo F; Buehler PW
Expert Opin Biol Ther; 2007 May; 7(5):665-75. PubMed ID: 17477804
[TBL] [Abstract][Full Text] [Related]
12. Immune effects of decreasing low-molecular weight hemoglobin components of hemoglobin-based oxygen carriers (HBOC) in a swine model of severe controlled hemorrhagic shock.
VanderMolen C; Malkevich N; Philbin N; Rice J; Collier S; Hall C; Ahlers S; McCarron R; Freilich D; McGwin G; Pearce LB
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(5):507-17. PubMed ID: 17922315
[TBL] [Abstract][Full Text] [Related]
13. Acellular invertebrate hemoglobins as model therapeutic oxygen carriers: unique redox potentials.
Harrington JP; Kobayashi S; Dorman SC; Zito SL; Hirsch RE
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):53-67. PubMed ID: 17364471
[TBL] [Abstract][Full Text] [Related]
14. Hemospan: design principles for a new class of oxygen therapeutic.
Vandegriff KD; Winslow RM
Artif Organs; 2009 Feb; 33(2):133-8. PubMed ID: 19178457
[TBL] [Abstract][Full Text] [Related]
15. All hemoglobin-based oxygen carriers are not created equally.
Buehler PW; Alayash AI
Biochim Biophys Acta; 2008 Oct; 1784(10):1378-81. PubMed ID: 18206989
[TBL] [Abstract][Full Text] [Related]
16. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
Kim HW; Greenburg AG
Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
[TBL] [Abstract][Full Text] [Related]
17. Numerical simulation of oxygen delivery to muscle tissue in the presence of hemoglobin-based oxygen carriers.
Patton JN; Palmer AF
Biotechnol Prog; 2006; 22(4):1025-49. PubMed ID: 16889379
[TBL] [Abstract][Full Text] [Related]
18. Unique tryptic peptides specific for bovine and human hemoglobin in the detection and confirmation of hemoglobin-based oxygen carriers.
Guan F; Uboh C; Soma L; Luo Y; Driessen B
Anal Chem; 2004 Sep; 76(17):5118-26. PubMed ID: 15373451
[TBL] [Abstract][Full Text] [Related]
19. [Blood substitutes: state of the art and technical setbacks and why we are still disappointed].
Vigneron C; Smani Y; Faivre B
Bull Acad Natl Med; 2007; 191(4-5):837-47; discussion 847. PubMed ID: 18225438
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock.
Raat NJ; Liu JF; Doyle MP; Burhop KE; Klein J; Ince C
J Lab Clin Med; 2005 Jan; 145(1):21-32. PubMed ID: 15668658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
